top of page
QSAM Biosciences Closes Series B Preferred Private Placement led by Checkmate Capital.
Austin, Texas, Jan. 28, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation nuclear...
Checkmate Capital Group Completes Seed Investment in Lactiga, Inc.
PRINCETON, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Lactiga, Inc. (“Lactiga”), an award-winning biotherapeutics company developing...
NeuroSigma Receives Bridge Financing from Checkmate Capital
To Support Targeted Commercialization and Global Partnering of FDA-Approved Non-Drug Treatment for Pediatric ADHD LOS ANGELES, Sept. 21,...
Monarch Biosciences Closes Seed Round Financing
Led by Checkmate Capital Group Development of Biomaterial-based Neurovascular Stent and Platform for Local Delivery of Cell Therapies LOS...
Press
bottom of page